- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0118446

Morkem Pharmaceuticals Private Limited
About Morkem Pharmaceuticals Private Limited
Data last updated:
Morkem Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 24 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC287110. Its GSTIN is 27AAKCM6313M1Z3 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Maneka Rajkumar Prasad Mathur and Sumit Mathur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wing Shree Laxmi Vaibhav Chs Beverlery Park, Thane, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹52.76 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹25,012 (net margin 0.5%) and EBITDA of ₹40,184 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 79% over five years.
Morkem Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0118446). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Morkem Pharmaceuticals
Contact details
Morkem Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address003/C – Wing Shree Laxmi Vaibhav Chs Beverlery Park Mira – Bhayander Cross Road Mira Ro, Ad East, Thane, Maharashtra, India – 401107
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Morkem Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Morkem Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Morkem Pharmaceuticals Private Limited, buy the company report.
Financials of Morkem Pharmaceuticals Private Limited
FY 2025 filings availableMorkem Pharmaceuticals Private Limited reported revenue of ₹52.76 Lakh (down 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 79%. EBITDA fell 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹40,184 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25,012 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Morkem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Morkem Pharmaceuticals Private Limited
Morkem Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maneka Rajkumar Prasad Mathur | Director | 24 Oct 2016 | 10 Years 0 Months | Current |
| Sumit Mathur Also directs: Santelmmune Biologics Private Limited, A-Rich Lab Private Limited | Director | 24 Oct 2016 | 10 Years 0 Months | Current |
Auditor
Morkem Pharmaceuticals Private Limited is audited by A A SHAH AND CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A A SHAH AND CO | FY 2017 | 160612 |
Shareholding
The shareholding of Morkem Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Morkem Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Morkem Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Morkem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Morkem Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCM6313M1Z3 | Maharashtra | Active | 24 Nov 2017 |
To see the full GST registrations and return filing status of Morkem Pharmaceuticals Private Limited, buy the company report.
Recent activity
Morkem Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Maneka Rajkumar Prasad Mathur was appointed as Director on 24 Oct 2016.
Frequently asked questions
Morkem Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 24 October 2016 (10+ years old) and is registered under CIN U74999MH2016PTC287110.
Morkem Pharmaceuticals has 2 current directors:
- Maneka Rajkumar Prasad Mathur - Director
- Sumit Mathur - Director
The latest financial statements of Morkem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Morkem Pharmaceuticals is 27AAKCM6313M1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Morkem Pharmaceuticals is U74999MH2016PTC287110. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Morkem Pharmaceuticals was incorporated on 24 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Maneka Rajkumar Prasad Mathur was appointed as Director on 24 Oct 2016. Sumit Mathur was appointed as Director on 24 Oct 2016.
Yes, Morkem Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0118446).
The registered office of Morkem Pharmaceuticals is at 003C – Wing Shree Laxmi Vaibhav Chs Beverlery Park Mira – Bhayander Cross Road Mira Ro, Ad East, Thane, Maharashtra, India – 401107.
Morkem Pharmaceuticals operates in the business services industry, in the other services segment.

